ArriVent BioPharma, Inc. Common Stock (AVBP)
NASDAQ·Healthcare·Biotechnology
$31.22
+2.93%
Mkt Cap $1.42B
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (7 analysts)
$44.00
Range $43.00 – $45.00
Implied Upside
+40.9%
Consensus $44.00 vs current $31.22